Publications Toxicology

Klotz K, Weistenhöfer W, Neff F, Hartwig A, van Thriel C, Drexler H:

The health effects of aluminum exposure. Dtsch Arztebl Int 114: 653-659 (2017)

Hengstler JG:

Intravitale Bildgebung basierend auf Zwei-Photonen Mikroskopie. In: Dreßler J, Maatz R, Daldrup T (Hrsg.): Toxikologie und Umfeld. Beiträge zum Symposium des Instituts für Rechtsmedizin der Universität Leipzig, 28. Sept. 2016, Forschungszentrum des Universitätsklinikums (S 160-163). Leipzig: MOLINApress, 2017

Schenk A, Ghallab A, Hofmann U, Hassan R, Schwarz M, Schuppert A, Schwen LO, Braeuning A, Teutonico D, Hengstler JG, Kuepfer L:

Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage. Sci Rep 7(1): 6224 (2017) (13 pp)

Selinski S:

Discovering urinary bladder cancer risk variants: status quo after almost ten years of genome-wide association studies. (Guest editorial). EXCLI J 16: 1288-1296 (2017)

Schriewer A, Cadenas C, Hayen H:

Hydrophilic interaction liquid chromatography tandem mass spectrometry analysis of malonyl-coenzyme A in breast cancer cell cultures applying online solid-phase extraction. J Sep Sci 40: 4303-4310 (2017)

Schriewer A, Brink M, Gianmoena K, Cadenas C, Hayen H:

Oxalic acid quantification in mouse urine and primary mouse hepatocyte cell culture samples by ion exclusion chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1068-1069: 239-244 (2017)

Selinski S, Blaszkewicz M, Ickstadt K, Gerullis H, Otto T, Roth E, Volkert F, Ovsiannikov D, Moormann O, Banfi G, Nyirady P, Vermeulen SH, Garcia-Closas M, Figueroa JD, Johnson A, Karagas MR, Kogevinas M, Malats N, Schwenn M, Silverman DT, Koutros S, Rothman N, Kiemeney LA, Hengstler JG, Golka K:

Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer. Carcinogenesis 38: 1167-1179 (2017)

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (u.a. Bolt HM):

Some chemicals used as solvents and in polymer manufacture [Perfluorooctanoic acid, tetrafluoroethylen, dichloromethane, 1,2-dichloropropane, and 1,3-propane sultone]. Lyon: IARC, 2017 (IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 110)

Bock KW, Bolt HM, Greim H:

Herbert Remmer, Prof. Dr. med. Wissenschaftliche Biographie. In: Philippu A (Hrsg.): Geschichte und Wirken der pharmakologischen, klinisch-pharmakologischen und toxikologischen Institute im deutschsprachigen Raum, Bd. V: Autobiographien II und asusgewählte Biographien (S 361-369). Innsbruck: Berenkamp, 2017

Engel J, Smith S, Lategahn J, Tumbrink HL, Goebel L, Becker C, Hennes E, Keul M, Unger A, Müller H, Baumann M, Schultz-Fademrecht C, Günther G, Hengstler JG, Rauh D:

Structure-guided development of covalent and mutant-selective pyrazolopyrimidines to target T790M drug resistance in epidermal growth factor receptor. J Med Chem 60: 7725-7744 (2017)